论文部分内容阅读
我院采用抗结核药物经由气管内滴入法治疗肺结核空洞,迄今已有8年。在此8年中,我们在方法上曾略有改变,如最初是单纯以链霉素或异烟肼溶液滴入空洞,先确定滴入法的疗效和它的优点,以后再配合全身的一般治疗。我们在大闹技术革新时又在抗结核药物中加添了气管舒张剂和皮激素、类激素等类药物同时合并滴入,因病例尚少,且多在继续治疗中,故尚不能得出结论,容后再另文报告。气管内药物滴入法治疗肺结核空洞,若选择病例不当,则疗效不若理想之高。它并非万应方法,在若干情况下是受到相当限制的,甚至还有禁忌症存在。目前若干医者对之期望过高,将一些毫无办法四周瀰
Our hospital has adopted anti-TB drugs through the endotracheal infusion of tuberculosis cavity, so far, 8 years. In this 8 years, we have a slight change in the method, such as the first is simply to streptomycin or isoniazid solution into the cavity, first determine the efficacy of the drop method and its advantages, and then with the general body treatment. When we made technical innovations in anti-tuberculosis drugs, we added tracheal and diastolic agents and dermal hormones. Hormones and other drugs were combined and dripped at the same time. Due to the small number of cases and the continued treatment, we can not conclude Conclusion, then another report after the content. Intratracheal drug infusion method for the treatment of pulmonary tuberculosis, if the inappropriate choice of the case, then the effect is not ideal high. It is not a panoply, in some cases is subject to considerable restrictions, and even contraindications exist. At present, some doctors expect too much, and there will be no solution for them